Ventyx Biosciences, Inc. (VTYX)
8.695
+0.18
(+2.17%)
USD |
NASDAQ |
Dec 10, 16:00
8.695
0.00 (0.00%)
After-Hours: 19:26
Ventyx Biosciences Total Liabilities (Quarterly): 20.10M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 26.38M |
| Genprex, Inc. | 2.795M |
| Moderna, Inc. | 2.805B |
| Neumora Therapeutics, Inc. | 45.67M |
| BioAge Labs, Inc. | 27.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 211.46M |
| Shareholders Equity (Quarterly) | 191.36M |
| Debt to Equity Ratio | 0.0524 |
| Current Ratio | 17.86 |
| Net Debt Paydown Yield | 0.11% |